FDA cleared the Dynavisc from Fziomed, Inc. on Oct 28, 2026 under K262343, a traditional 510(k). The device falls under product code OWW, Mesh, Surgical, Absorbable, Orthopaedics, Reinforcement Of Tendon, regulated at 21 CFR 878.3300 as a Class 2 device. The review panel was General, Plastic Surgery.
FDA logged the submission as received on Jul 10, 2026. The decision came 110 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
Fziomed, Inc. has one other decision in the tracker over the last 12 months: K253326 (Oxiplex).